Nanocarry Therapeutics
Nanoparticle-based Therapeutics for Brain Cancer and CNS Disorders
StartupNanocarry Therapeutics is a Ness Ziona-based startup in the Health Tech & Life Sciences sector, established in 2021. Nanoparticle-based Therapeutics for Brain Cancer and CNS Disorders. The company has raised a total of $1M across 4 funding rounds, currently at the Pre-Seed stage. Nanocarry Therapeutics was founded by Revital Mandil Levin, Rachela Popovtzer, Oshra Betzer. Key investors include Sapir Venture Partners, NFX Capital, Teramips Technologies. The company has 11-50 employees. Core technologies: Biologicals, Cells.
With $1M in total funding, Nanocarry Therapeutics is a Pre-Seed-stage company operating in Health Tech & Life Sciences. The company follows a B2C business model. Product stage: Clinical Trial.
- StagePre-Seed
- ProductClinical Trial
- ModelB2C
- Employees11-50
- HQNess Ziona
- DistrictCenter District
- Last RoundUndisclosed
- Sapir Venture PartnersLead
- NFX Capital
- Teramips Technologies
Revital Mandil LevinCo-founder & CEO
Rachela PopovtzerCo-founder & CSO
Oshra BetzerCo-founder & CTO
What does Nanocarry Therapeutics do?
Nanocarry is developing therapeutics based on bioengineered nanoparticles with novel capabilities to treat oncology indications and brain diseases. The company’s AxS platform can be easily modified to deliver a wide array of biologics, safely and effectively, to the brain and beyond. Nanocarry’s first products in development are for brain metastases of HER2+ breast cancer and non-small cell lung cancer.
How much funding has Nanocarry Therapeutics raised?
Nanocarry Therapeutics has raised $1M in total funding across 4 rounds. The company is currently at the Pre-Seed stage. Key investors include Sapir Venture Partners, NFX Capital, Teramips Technologies.
Who founded Nanocarry Therapeutics?
Nanocarry Therapeutics was founded in 2021 by Revital Mandil Levin (Co-founder & CEO), Rachela Popovtzer (Co-founder & CSO), Oshra Betzer (Co-founder & CTO).
What sector is Nanocarry Therapeutics in?
Nanocarry Therapeutics operates in Health Tech & Life Sciences, Digital Healthcare, Digital Therapeutics, Pharma & Medical Biotechnology, Drugs Discovery & Development, with core technologies in Biologicals, Cells. Target customers: Healthcare & Life Sciences, Life Sciences, Biotechnology, Pharmaceuticals.
Where is Nanocarry Therapeutics located?
Nanocarry Therapeutics is based in Pinhas Sapir Street 3, Ness Ziona, Israel, Center District.